Global Plasma Therapy Market 2024 , Forecast To 2033
7 Mar, 2024
The plasma therapy market (10) has experienced rapid growth, expected to rise from $0.49 billion in 2023 to $0.55 billion in 2024 at a CAGR of 11.4%, driven by factors including increasing awareness and demand for personalized medicine. Looking forward, the market is anticipated to continue its rapid growth, reaching $0.88 billion in 2028 at a CAGR of 12.5%, fueled by expanding applications and customized therapies, with trends such as improved techniques and telemedicine integration shaping its development.
Global Plasma Therapy Market Key Driver
The rising cases of osteoarthritis are expected to drive the plasma therapy market (10). With projected increases in osteoarthritis cases globally, platelet-rich plasma therapy is considered a safe and efficient treatment, thus driving market growth.
Get A Free Sample Of The Global Plasma Therapy Market ReportGlobal Plasma Therapy Market Segments
The plasma therapy market covered in this report is segmented –
1) By Type: Pure PRP, Leukocyte-rich PRP, Pure Platelet-rich Fibrin (PRF), Leukocyte-rich Fibrin (L-PRF)
2) By Application: Orthopaedics, Arthritis, Chronic Tendinitis, Bone Repair & Regeneration, Dermatology, Androgenic Alopecia, Plastic Surgery, Dental, Cardiac Muscle Injury, Other Applications
3) By End-Users: Hospitals & Clinics, Laboratories: Research Institutes
By Geography: The countries covered in the plasma therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
North America was the largest region in the plasma therapy market in 2023. The Middle East is expected to be the fastest-growing region in the global plasma therapy market share during the forecast period. The regions covered in the plasma therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Major Plasma Therapy Industry Players
Takeda Pharmaceutical Company Limited; Bio Products Laboratory Ltd.; Arthrex Inc.; Biotest AG; China Biologic Products Holdings Inc.; DePuy Synthes Companies; CSL Limited; Grifols S.A.; Octapharma AG; Terumo BCT Inc.; Pfizer Inc.; Kedrion Biopharma; ADMA Biologics Inc.; SK Plasma Co. Ltd.; Kamada Ltd.; Grifols International S.A.; Fusion HealthCare; LFB Plasma; Baxter International Inc.; Bayer AG; GC Biopharma Corp; Hualan Biological Engineering Inc.; Japan Blood Products Organization; PlasmaCare Inc.; ProMetic Life Sciences Inc.; Sanquin; Shanghai RAAS Blood Products Co. Ltd.; Canadian Plasma Resources; B Positive Plasma; Proesis Biologics Inc.
Get The Full Global Plasma Therapy Market Report
Plasma Therapy Market Overview
Plasma therapy refers to a treatment that substitutes missing or inadequate proteins to help people live healthier and more fruitful lives. It introduces antibodies into individuals receiving therapy using blood donated by recovered patients.